Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

ClinicalTrials.gov ID: NCT01369095

Public ClinicalTrials.gov record NCT01369095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients With Treatment Resistant Major Depression (TRD).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the efficacy of study drug (BMS-820836) as compared with continued Duloxetine/Escitalopram in the treatment of patients with treatment resistant depression (TRD).

Study identification

NCT ID
NCT01369095
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
976 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2011 (Type not available)
Primary completion
May 2013 (Actual)
Completion
May 2013 (Actual)
Last update posted
Oct 12, 2015

2011 – 2013

United States locations

U.S. sites
48
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Birmingham Psychiatry Pharmaceutical Studies, Inc. Birmingham Alabama 35226 —
Arkansas Psychiatric Clinic Clinical Research Trials, P.A. Little Rock Arkansas 72223 —
Catalina Research Institute, Llc Chino California 91710 —
Behavioral Research Specialists, Llc Glendale California 91206 —
Pacific Clinical Research Medical Group Orange California 92868 —
Anderson Clinical Research Redlands California 92374 —
Affiliated Research Institute San Diego California 92108 —
Artemis Institute For Clinical Research San Diego California 92123 —
Sharp Mesa Vista Hospital San Diego California 92123 —
Western Affiliated Research Institute Denver Colorado 80209 —
Connecticut Clinical Research Cromwell Connecticut 06416 —
Meridien Research Brooksville Florida 34601 —
Gulfcoast Clinical Research Center Fort Myers Florida 33912 —
Amit Vijapura Jacksonville Florida 32256 —
Stedman Clinical Trials Tampa Florida 33613 —
Janus Center For Psychiatric Research West Palm Beach Florida 33407 —
Emory University Atlanta Georgia 30306 —
Uptown Research Institute, Llc Chicago Illinois 60640 —
Clinco Terre Haute Indiana 47802 —
Clinical Trials Technology, Inc Prairie Village Kansas 66206 —
Ert Shreveport Louisiana 71104 —
Mclean Hospital Belmont Massachusetts 02478 —
Bio Behavioral Health Toms River New Jersey 08755 —
Albuquerque Neuroscience, Inc. Albuquerque New Mexico 87109 —
Comprehensive Clinical Development, Inc Fresh Meadows New York 11366 —
Bioscience Research, Llc Mount Kisco New York 10549 —
Village Clinical Research, Inc. New York New York 10003 —
Northcoast Clinical Trials, Inc Beachwood Ohio 44122 —
Patient Priority Clinical Sites, Llc Cincinnati Ohio 45215 —
Neurology & Neuroscience Center Of Ohio Toledo Ohio 43623 —
Suburban Research Associates Media Pennsylvania 19063 —
Keystone Clinical Studies, Llc Norristown Pennsylvania 19403 —
Ert Pittsburgh Pennsylvania 15219 —
Neuropsychiatric Research Center Of Orange County Pittsburgh Pennsylvania 15219 —
Northwest Clinical Research Center Pittsburgh Pennsylvania 15219 —
Lincoln Research Lincoln Rhode Island 02865 —
Future Search Trials Austin Texas 78731 —
Futuresearch Trials Of Dallas Dallas Texas 75231 —
Insite Clinical Research DeSoto Texas 75115 —
Ben Taub General Hospital Houston Texas 77030 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —
Ericksen Research And Development Clinton Utah 84015 —
Clinical Methods Llc Murray Utah 84107 —
Neuropsychiatric Associates Woodstock Vermont 05091 —
Neuroscience, Inc Herndon Virginia 20170 —
Virginia Commonwealth University Richmond Virginia 23219 —
Summit Research Network (Seattle) Llc Seattle Washington 98104 —
Dean Foundation For Health Research & Education Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01369095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 12, 2015 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01369095 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →